Cutler Group LP Genprex, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$3.03 - $5.51 $8,611 - $15,659	-2,842 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$2.9 - $4.29 $4,471 - $6,615	1,542 Added 118.62%	2,842 $9,000
Q2 2020 Jul 22, 2020	SELL	$1.99 - $3.64 $199 - $364	-100 Reduced 7.14%	1,300 $4,000
Q1 2020 May 07, 2020	BUY	$0.28 - $6.23 $392 - $8,722	1,400 New	1,400 $3,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.